To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years

NCT05389137 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Inavtivated Quadrivalent Influenza Virus Split Vaccine

Sponsor

Wuhan Institute of Biological Products Co., Ltd